Exagen Inc. (XGN)
NASDAQ: XGN · IEX Real-Time Price · USD
1.410
+0.010 (0.71%)
Apr 26, 2024, 9:30 AM EDT - Market open

Exagen Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Net Income
-23.69-47.39-26.85-16.69-30.28-18.48-32.77
Depreciation & Amortization
3.112.520.950.550.590.730.67
Share-Based Compensation
3.624.74.732.690.570.110.19
Other Operating Activities
2.58.020.91-0.641.16-2.1313.81
Operating Cash Flow
-14.46-32.14-20.27-14.08-9.71-9.3-10.97
Capital Expenditures
-0.8-4.32-2.37-0.46-0.1-0.2-0.51
Other Investing Activities
---0.05----
Investing Cash Flow
-0.8-4.32-2.42-0.46-0.1-0.2-0.51
Share Issuance / Repurchase
0.310.4565.250.1750.4400
Debt Issued / Paid
-10.94-0.7-0.53-0.25-0.144.964.51
Other Financing Activities
--0.24-0.04-0.0218.436.4714.64
Financing Cash Flow
-10.63-0.4964.68-0.168.7311.4219.16
Net Cash Flow
-25.9-36.9541.99-14.6458.921.927.68
Free Cash Flow
-15.27-36.46-22.64-14.54-9.81-9.5-11.48
Free Cash Flow Margin
-29.05%-80.03%-46.87%-34.64%-24.30%-29.28%-42.82%
Free Cash Flow Per Share
-0.86-2.13-1.42-1.15-2.74-150.78-182.18
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).